Castrate-resistant Prostate Cancer Market Is Estimated To Witness...

added article Health

2023-10-20 10:03:07 -

Castrate-resistant Prostate Cancer Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Prostate Cancer & Increasing R&D Activities

Market Overview:Castrate-resistant prostate cancer (CRPC) refers to prostate cancer that continues to grow even after the medical or surgical castration treatment of prostate cancer. It occurs when prostate cancer no longer respond to hormonal therapy and it begins to spread further. The treatment options for CRPC includes chemotherapy, radiotherapy, targeted therapy and immunotherapy.Market...

0 Comments 0 Shares 1039 Views 0 Reviews